The "ADAPTIVE BIOTECHNOLOGIES" trademark, serial number 86213047 , was filed on 6th of March 2014 with a mark drawing code of 4000 and its transaction date is 86213047. Since 11th of June 2014, the document can be found in the L10 law office in the publication and issue section. The status of this trademark was checked last on 06/11/2014.

Prior registrations: 4420529

The corresponded responsible for this trademark is ADAPTIVE BIOTECHNOLOGIES CORP., located at ADAPTIVE BIOTECHNOLOGIES CORP., 1551 EASTLAKE AVE E STE 200, SEATTLE, WA 98102-7402.

The state or country where the trademark was organized is WA by Adaptive Biotechnologies Corp.. The legal entity type behing it is a Corporation, located at 1551 Eastlake Ave East Suite 200, Seattle, WA zip 98102.

GOODS AND/OR SERVICES
International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
U.S. Class	101 - Advertising and Business
Class Status	6 - Active
Status Date	03/19/2014
First Use Date	09/08/2009
First Use in Commerce Date	09/08/2009
Primary Code	042
Goods codes
D10000	"BIOTECHNOLOGIES"
GS0421	Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Custom design and development of chemical reagents and biochemical assays; Development of new technology for others in the field of immunotherapy; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Genetic testing for scientific research purposes; Genome amplification; Genotyping services for research or analysis purposes; Laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of immunotherapy; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines

PROSECUTION HISTORY
Date	Description	Type	Code
06/11/2014	COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED	I - Incoming Correspondence	CEPE - COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
06/11/2014	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
06/11/2014	NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED	O - Outgoing Correspondence	GEAN
06/11/2014	EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED	F - First Action	GEAP - EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/11/2014	EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED	R - Renewal	CPEA - EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
06/10/2014	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
03/19/2014	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
03/10/2014	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.